These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. Zhang F; Xu S; Iadecola C J Cereb Blood Flow Metab; 1995 Jul; 15(4):595-601. PubMed ID: 7540621 [TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Nishikawa T; Kirsch JR; Koehler RC; Bredt DS; Snyder SH; Traystman RJ Stroke; 1993 Nov; 24(11):1717-24. PubMed ID: 7694394 [TBL] [Abstract][Full Text] [Related]
7. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup. Ashwal S; Cole DJ; Osborne S; Osborne TN; Pearce WJ Pediatr Res; 1995 Nov; 38(5):652-6. PubMed ID: 8552429 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Horiguchi T; Snipes JA; Kis B; Shimizu K; Busija DW Neuroscience; 2006 Jun; 140(2):723-30. PubMed ID: 16567054 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat. Coert BA; Anderson RE; Meyer FB J Neurosurg; 1999 Feb; 90(2):332-8. PubMed ID: 9950505 [TBL] [Abstract][Full Text] [Related]
11. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA; Graham DI; McCulloch J; Macrae IM Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111 [TBL] [Abstract][Full Text] [Related]
12. Effects of central inhibition of nitric oxide synthase on focal cerebral ischemia in rats. Hamada J; Greenberg JH; Croul S; Dawson TM; Reivich M J Cereb Blood Flow Metab; 1995 Sep; 15(5):779-86. PubMed ID: 7545692 [TBL] [Abstract][Full Text] [Related]
13. Fructose-1,6-bisphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats. Kuluz JW; Gregory GA; Han Y; Dietrich WD; Schleien CL Stroke; 1993 Oct; 24(10):1576-83. PubMed ID: 8378964 [TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Zhang F; Casey RM; Ross ME; Iadecola C Stroke; 1996 Feb; 27(2):317-23. PubMed ID: 8571430 [TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent reperfusion and nitric oxide synthase inhibition on infarct volume during reversible focal cerebral ischemia. Iuliano BA; Anderson RE; Meyer FB J Neurosurg; 1995 Sep; 83(3):491-5. PubMed ID: 7666228 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats. Toung TJ; Bhardwaj A; Dawson VL; Dawson TM; Traystman RJ; Hurn PD Stroke; 1999 Jun; 30(6):1279-85. PubMed ID: 10356112 [TBL] [Abstract][Full Text] [Related]